Nuveen Asset Management

Nuveen Asset Management Portfolio holdings

AUM $354B
 

Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.

This Quarter Return
-16.56%
1 Year Return
+34.48%
3 Year Return
+60.43%
5 Year Return
+189.89%
10 Year Return
+390.34%
AUM
$205B
AUM Growth
+$205B
Cap. Flow
-$2.21B
Cap. Flow %
-1.08%
Top 10 Hldgs %
21.11%
Holding
3,229
New
55
Increased
1,593
Reduced
1,390
Closed
86

Sector Composition

1 Technology 22.26%
2 Healthcare 14.77%
3 Financials 12.79%
4 Consumer Discretionary 10.52%
5 Communication Services 9.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
REGN icon
76
Regeneron Pharmaceuticals
REGN
$61.2B
$593M 0.29%
1,214,616
+428,361
+54% +$209M
LMT icon
77
Lockheed Martin
LMT
$105B
$559M 0.27%
1,650,088
-88,372
-5% -$30M
MNST icon
78
Monster Beverage
MNST
$61.5B
$555M 0.27%
9,859,362
+521,248
+6% +$29.3M
ROP icon
79
Roper Technologies
ROP
$55.8B
$544M 0.27%
1,745,291
-93,161
-5% -$29M
DHR icon
80
Danaher
DHR
$144B
$539M 0.26%
3,895,483
+274,252
+8% +$38M
TMO icon
81
Thermo Fisher Scientific
TMO
$183B
$539M 0.26%
1,900,512
+223,193
+13% +$63.3M
CCI icon
82
Crown Castle
CCI
$42.9B
$537M 0.26%
3,715,667
+570,589
+18% +$82.4M
ELV icon
83
Elevance Health
ELV
$71.9B
$529M 0.26%
2,329,409
+306,729
+15% +$69.6M
CL icon
84
Colgate-Palmolive
CL
$67.3B
$528M 0.26%
7,956,883
+1,394,544
+21% +$92.5M
QCOM icon
85
Qualcomm
QCOM
$169B
$519M 0.25%
7,665,864
-526,178
-6% -$35.6M
AEP icon
86
American Electric Power
AEP
$58.6B
$517M 0.25%
6,470,331
+2,560,683
+65% +$205M
WFC icon
87
Wells Fargo
WFC
$257B
$517M 0.25%
18,017,340
-2,614,011
-13% -$75M
LRCX icon
88
Lam Research
LRCX
$123B
$507M 0.25%
2,112,376
+516,115
+32% +$124M
MMC icon
89
Marsh & McLennan
MMC
$101B
$507M 0.25%
5,862,856
+1,086,300
+23% +$93.9M
CB icon
90
Chubb
CB
$110B
$507M 0.25%
4,536,161
+246,467
+6% +$27.5M
TJX icon
91
TJX Companies
TJX
$155B
$507M 0.25%
10,596,523
+4,800,639
+83% +$230M
NOC icon
92
Northrop Grumman
NOC
$82.9B
$506M 0.25%
1,673,824
-131,382
-7% -$39.7M
FE icon
93
FirstEnergy
FE
$24.9B
$498M 0.24%
12,437,539
-916,461
-7% -$36.7M
TGT icon
94
Target
TGT
$41.9B
$497M 0.24%
5,340,745
+202,855
+4% +$18.9M
AMD icon
95
Advanced Micro Devices
AMD
$262B
$486M 0.24%
10,690,904
+687,813
+7% +$31.3M
BLK icon
96
Blackrock
BLK
$170B
$486M 0.24%
1,103,865
+382,127
+53% +$168M
SCHW icon
97
Charles Schwab
SCHW
$174B
$484M 0.24%
14,386,349
+2,621,876
+22% +$88.1M
BA icon
98
Boeing
BA
$175B
$481M 0.23%
3,226,013
-1,212,742
-27% -$181M
D icon
99
Dominion Energy
D
$50B
$480M 0.23%
6,647,232
+1,435,234
+28% +$104M
CME icon
100
CME Group
CME
$96.5B
$477M 0.23%
2,760,405
-268,166
-9% -$46.4M